 | • レポートコード：QY20ST-06473 • 出版社/出版日：QYResearch / 2020年9月15日 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、132ページ • 納品方法：Eメール（受注後2~3営業日） • 産業分類：医薬品、医療 |
| Single User | ￥580,000 (USD4,000) | ▷ お問い合わせ |
| Multi User | ￥870,000 (USD6,000) | ▷ お問い合わせ |
| Enterprise License | ￥1,160,000 (USD8,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、世界の予防ワクチン市場について種類別（筋肉内注射、点鼻薬、皮内注射）、用途別（病院、クリニック、その他）、地域別（北米、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2015年～2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。市場予測データは新型コロナウイルスの影響を反映させました。 ・予防ワクチン市場の概要 ・世界の主要地域別予防ワクチン市場規模2015-2026 ・主要プレイヤーの競争状況・市場シェア ・世界の予防ワクチン市場規模2015-2026：種類別（筋肉内注射、点鼻薬、皮内注射） ・世界の予防ワクチン市場規模2015-2026：用途別（病院、クリニック、その他） ・予防ワクチンの北米市場規模2015-2020 ・予防ワクチンのヨーロッパ市場規模2015-2020 ・予防ワクチンの中国市場規模2015-2020 ・予防ワクチンの日本市場規模2015-2020 ・予防ワクチンの東南アジア市場規模2015-2020 ・予防ワクチンのインド市場規模2015-2020 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 ・予防ワクチンの製造コスト分析 ・販売チャネル、流通業者、顧客 ・予防ワクチンの市場動向・機会・課題 ・調査の結論 |
Preventive vaccines are targeted at healthy populations and are available to susceptible populations.It refers to the preventive vaccination of the patient before the infection of the pathogen or in the body without the disease.
Market Analysis and Insights: Global Preventive Vaccines Market
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Preventive Vaccines market in 2020.
COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.
The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyses the impact of Coronavirus COVID-19 on the Preventive Vaccines industry.
Based on our recent survey, we have several different scenarios about the Preventive Vaccines YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ xx million in 2019. The market size of Preventive Vaccines will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.
Global Preventive Vaccines Scope and Market Size
The global Preventive Vaccines market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Preventive Vaccines market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Preventive Vaccines market is segmented into
Intramuscular Injection
Nasal Spray
Intradermal Shot
Segment by Application, the Preventive Vaccines market is segmented into
Hospital
Clinic
Other
The Preventive Vaccines market is analysed and market size information is provided by regions (countries). Segment by Application, the Preventive Vaccines market is segmented into United States, Europe, China, Japan, Southeast Asia, India and Rest of World.
The report includes region-wise market size for the period 2015-2026. It also includes market size and forecast by players, by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Preventive Vaccines Market Share Analysis
Preventive Vaccines market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Preventive Vaccines business, the date to enter into the Preventive Vaccines market, Preventive Vaccines product introduction, recent developments, etc.
The major vendors covered:
Sanofi
AstraZeneca
CSL Ltd
Abbott
GlaxoSmithKline
Serum Institute of India
…
1 Preventive Vaccines Market Overview
1.1 Preventive Vaccines Product Scope
1.2 Preventive Vaccines Segment by Type
1.2.1 Global Preventive Vaccines Sales by Type (2020-2026)
1.2.2 Intramuscular Injection
1.2.3 Nasal Spray
1.2.4 Intradermal Shot
1.3 Preventive Vaccines Segment by Application
1.3.1 Global Preventive Vaccines Sales Comparison by Application (2020-2026)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Other
1.4 Preventive Vaccines Market Estimates and Forecasts (2015-2026)
1.4.1 Global Preventive Vaccines Sales Growth Rate (2015-2026)
1.4.2 Global Preventive Vaccines Revenue and Growth Rate (2015-2026)
1.4.3 Global Preventive Vaccines Price Trends (2015-2026)
1.5 Coronavirus Disease 2019 (Covid-19): Preventive Vaccines Industry Impact
1.5.1 How the Covid-19 is Affecting the Preventive Vaccines Industry
1.5.1.1 Preventive Vaccines Business Impact Assessment – Covid-19
1.5.1.2 Supply Chain Challenges
1.5.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.5.2 Market Trends and Preventive Vaccines Potential Opportunities in the COVID-19 Landscape
1.5.3 Measures / Proposal against Covid-19
1.5.3.1 Government Measures to Combat Covid-19 Impact
1.5.3.2 Proposal for Preventive Vaccines Players to Combat Covid-19 Impact
2 Preventive Vaccines Estimate and Forecast by Region
2.1 Global Preventive Vaccines Market Size by Region: 2015 VS 2020 VS 2026
2.2 Global Preventive Vaccines Retrospective Market Scenario by Region (2015-2020)
2.2.1 Global Preventive Vaccines Sales Market Share by Region (2015-2020)
2.2.2 Global Preventive Vaccines Revenue Market Share by Region (2015-2020)
2.3 Global Preventive Vaccines Market Estimates and Forecasts by Region (2021-2026)
2.3.1 Global Preventive Vaccines Sales Estimates and Forecasts by Region (2021-2026)
2.3.2 Global Preventive Vaccines Revenue Forecast by Region (2021-2026)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States Preventive Vaccines Estimates and Projections (2015-2026)
2.4.2 Europe Preventive Vaccines Estimates and Projections (2015-2026)
2.4.3 China Preventive Vaccines Estimates and Projections (2015-2026)
2.4.4 Japan Preventive Vaccines Estimates and Projections (2015-2026)
2.4.5 Southeast Asia Preventive Vaccines Estimates and Projections (2015-2026)
2.4.6 India Preventive Vaccines Estimates and Projections (2015-2026)
3 Global Preventive Vaccines Competition Landscape by Players
3.1 Global Top Preventive Vaccines Players by Sales (2015-2020)
3.2 Global Top Preventive Vaccines Players by Revenue (2015-2020)
3.3 Global Preventive Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Preventive Vaccines as of 2019)
3.4 Global Preventive Vaccines Average Price by Company (2015-2020)
3.5 Manufacturers Preventive Vaccines Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3.7 Primary Interviews with Key Preventive Vaccines Players (Opinion Leaders)
4 Global Preventive Vaccines Market Size by Type
4.1 Global Preventive Vaccines Historic Market Review by Type (2015-2020)
4.1.1 Global Preventive Vaccines Sales Market Share by Type (2015-2020)
4.1.2 Global Preventive Vaccines Revenue Market Share by Type (2015-2020)
4.1.3 Global Preventive Vaccines Price by Type (2014-2020)
4.2 Global Preventive Vaccines Market Estimates and Forecasts by Type (2021-2026)
4.2.1 Global Preventive Vaccines Sales Forecast by Type (2021-2026)
4.2.2 Global Preventive Vaccines Revenue Forecast by Type (2021-2026)
4.2.3 Global Preventive Vaccines Price Forecast by Type (2021-2026)
5 Global Preventive Vaccines Market Size by Application
5.1 Global Preventive Vaccines Historic Market Review by Application (2015-2020)
5.1.1 Global Preventive Vaccines Sales Market Share by Application (2015-2020)
5.1.2 Global Preventive Vaccines Revenue Market Share by Application (2015-2020)
5.1.3 Global Preventive Vaccines Price by Application (2015-2020)
5.2 Global Preventive Vaccines Market Estimates and Forecasts by Application (2021-2026)
5.2.1 Global Preventive Vaccines Sales Forecast by Application (2021-2026)
5.2.2 Global Preventive Vaccines Revenue Forecast by Application (2021-2026)
5.2.3 Global Preventive Vaccines Price Forecast by Application (2021-2026)
3 North America Preventive Vaccines Market Facts & Figures
3.2 North America Preventive Vaccines Sales Market Share by Company (2015-2020)
3.3 North America Preventive Vaccines Sales Market Share by Type (2015-2020)
3.4 North America Preventive Vaccines Sales Market Share by Application (2015-2020)
4 Europe Preventive Vaccines Market Facts & Figures
4.2 Europe Preventive Vaccines Sales Market Share by Company (2015-2020)
4.3 Europe Preventive Vaccines Sales Market Share by Type (2015-2020)
4.4 Europe Preventive Vaccines Sales Market Share by Application (2015-2020)
5 China Preventive Vaccines Market Facts & Figures
5.2 China Preventive Vaccines Sales Market Share by Company (2015-2020)
5.3 China Preventive Vaccines Sales Market Share by Type (2015-2020)
5.4 China Preventive Vaccines Sales Market Share by Application (2015-2020)
6 Japan Preventive Vaccines Market Facts & Figures
6.2 Japan Preventive Vaccines Sales Market Share by Company (2015-2020)
6.3 Japan Preventive Vaccines Sales Market Share by Type (2015-2020)
6.4 Japan Preventive Vaccines Sales Market Share by Application (2015-2020)
7 Southeast Asia Preventive Vaccines Market Facts & Figures
7.2 Southeast Asia Preventive Vaccines Sales Market Share by Company (2015-2020)
7.3 Southeast Asia Preventive Vaccines Sales Market Share by Type (2015-2020)
7.4 Southeast Asia Preventive Vaccines Sales Market Share by Application (2015-2020)
8 India Preventive Vaccines Market Facts & Figures
8.2 India Preventive Vaccines Sales Market Share by Company (2015-2020)
8.3 India Preventive Vaccines Sales Market Share by Type (2015-2020)
8.4 India Preventive Vaccines Sales Market Share by Application (2015-2020)
12 Company Profiles and Key Figures in Preventive Vaccines Business
12.1 Sanofi
12.1.1 Sanofi Preventive Vaccines Corporation Information
12.1.2 Sanofi Preventive Vaccines Business Overview and Total Revenue
12.1.3 Sanofi Preventive Vaccines Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Sanofi Preventive Vaccines Products Offered
12.1.5 Sanofi Recent Development
12.2 AstraZeneca
12.2.1 AstraZeneca Preventive Vaccines Corporation Information
12.2.2 AstraZeneca Preventive Vaccines Business Overview and Total Revenue
12.2.3 AstraZeneca Preventive Vaccines Sales, Revenue and Gross Margin (2015-2020)
12.2.4 AstraZeneca Preventive Vaccines Products Offered
12.2.5 AstraZeneca Recent Development
12.3 CSL Ltd
12.3.1 CSL Ltd Preventive Vaccines Corporation Information
12.3.2 CSL Ltd Preventive Vaccines Business Overview and Total Revenue
12.3.3 CSL Ltd Preventive Vaccines Sales, Revenue and Gross Margin (2015-2020)
12.3.4 CSL Ltd Preventive Vaccines Products Offered
12.3.5 CSL Ltd Recent Development
12.4 Abbott
12.4.1 Abbott Preventive Vaccines Corporation Information
12.4.2 Abbott Preventive Vaccines Business Overview and Total Revenue
12.4.3 Abbott Preventive Vaccines Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Abbott Preventive Vaccines Products Offered
12.4.5 Abbott Recent Development
12.5 GlaxoSmithKline
12.5.1 GlaxoSmithKline Preventive Vaccines Corporation Information
12.5.2 GlaxoSmithKline Preventive Vaccines Business Overview and Total Revenue
12.5.3 GlaxoSmithKline Preventive Vaccines Sales, Revenue and Gross Margin (2015-2020)
12.5.4 GlaxoSmithKline Preventive Vaccines Products Offered
12.5.5 GlaxoSmithKline Recent Development
12.6 Serum Institute of India
12.6.1 Serum Institute of India Preventive Vaccines Corporation Information
12.6.2 Serum Institute of India Preventive Vaccines Business Overview and Total Revenue
12.6.3 Serum Institute of India Preventive Vaccines Sales, Revenue and Gross Margin (2015-2020)
12.6.4 Serum Institute of India Preventive Vaccines Products Offered
12.6.5 Serum Institute of India Recent Development
…
13 Preventive Vaccines Manufacturing Cost Analysis
13.1 Preventive Vaccines Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Preventive Vaccines
13.4 Preventive Vaccines Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Preventive Vaccines Distributors List
14.3 Preventive Vaccines Customers
15 Market Dynamics
15.1 Market Trends
15.2 Opportunities and Drivers
15.3 Challenges
15.4 Porter’s Five Forces Analysis
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global Preventive Vaccines Sales (K Doses) Growth Rate by Type (2020-2026)
Table 2. Global Preventive Vaccines Sales (K Doses) Comparison by Application (2020-2026)
Table 3. COVID-19 Impact Global Market: (Four Preventive Vaccines Market Size Forecast Scenarios)
Table 4. Opportunities and Trends for Preventive Vaccines Players in the COVID-19 Landscape
Table 5. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 6. Key Regions/Countries Measures against Covid-19 Impact
Table 7. Proposal for Preventive Vaccines Players to Combat Covid-19 Impact
Table 8. Global Market Preventive Vaccines Market Size (US$ Million) by Region:2015 VS 2020 &2026
Table 9. Global Preventive Vaccines Sales (K Doses) by Region (2015-2020)
Table 10. Global Preventive Vaccines Sales Market Share by Region (2015-2020)
Table 11. Global Preventive Vaccines Revenue (US$ Million) Market Share by Region (2015-2020))
Table 12. Global Preventive Vaccines Revenue Share by Region (2015-2020)
Table 13. Global Preventive Vaccines Sales (K Doses) Forecast by Region (2021-2026)
Table 14. Global Preventive Vaccines Sales Market Share Forecast by Region (2021-2026)
Table 15. Global Preventive Vaccines Revenue (US$ Million) Forecast by Region (2021-2026)
Table 16. Global Preventive Vaccines Revenue Share Forecast by Region (2021-2026)
Table 17. Global Preventive Vaccines (K Doses) of Key Companies (2015-2020)
Table 18. Global Preventive Vaccines Sales Share by Company (2015-2020)
Table 19. Global Preventive Vaccines Revenue (US$ Million) by Company (2015-2020)
Table 20. Global Preventive Vaccines Revenue Share by Company (2015-2020)
Table 21. Global Preventive Vaccines by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Preventive Vaccines as of 2019)
Table 22. Global Preventive Vaccines Average Price (USD/Doses) of Key Company (2015-2020)
Table 23. Manufacturers Preventive Vaccines Manufacturing Sites and Area Served
Table 24. Manufacturers Preventive Vaccines Product Type
Table 25. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 26. Main Points Interviewed from Key Preventive Vaccines Players
Table 27. Global Preventive Vaccines Sales (K Doses) by Type (2015-2020)
Table 28. Global Preventive Vaccines Sales Share by Type (2015-2020)
Table 29. Global Preventive Vaccines Revenue (US$ Million) Market Share by Type (2015-2020)
Table 30. Global Preventive Vaccines Price (K Doses) by Type (2015-2020)
Table 31. Global Preventive Vaccines Sales Share by Type (2021-2026)
Table 32. Global Preventive Vaccines Revenue (US$ Million) Market Share by Type (2021-2026)
Table 33. Global Preventive Vaccines Revenue Share by Type (2021-2026)
Table 34. Global Preventive Vaccines Price (K Doses) by Type (2021-2026)
Table 35. Global Preventive Vaccines Sales (K Doses) by Application (2015-2020)
Table 36. Global Preventive Vaccines Sales Share by Application (2015-2020)
Table 37. Global Preventive Vaccines Revenue (US$ Million) Market Share by Application (2015-2020)
Table 38. Global Preventive Vaccines Price (K Doses) by Application (2015-2020)
Table 39. Global Preventive Vaccines Sales (K Doses) by Application (2021-2026)
Table 40. Global Preventive Vaccines Sales Share by Application (2021-2026)
Table 41. Global Preventive Vaccines Revenue (US$ Million) Market Share by Application (2021-2026)
Table 42. Global Preventive Vaccines Revenue Share by Application (2021-2026)
Table 43. Global Preventive Vaccines Price (K Doses) by Application (2021-2026)
Table 44. United States Preventive Vaccines Sales (K Doses) by Company (2015-2020)
Table 45. United States Preventive Vaccines Sales Market Share by Company (2015-2020)
Table 46. United States Preventive Vaccines Sales (K Doses) by Type (2015-2020)
Table 47. United States Preventive Vaccines Sales Market Share by Type (2015-2020)
Table 48. United States Preventive Vaccines Sales (K Doses) by Application (2015-2020)
Table 49. United States Preventive Vaccines Sales Market Share by Application (2015-2020)
Table 50. Europe Preventive Vaccines Sales (K Doses) by Company (2015-2020)
Table 51. Europe Preventive Vaccines Sales Market Share by Company (2015-2020)
Table 52. Europe Preventive Vaccines Sales (K Doses) by Type (2015-2020)
Table 53. Europe Preventive Vaccines Sales Market Share by Type (2015-2020)
Table 54. Europe Preventive Vaccines Sales (K Doses) by Application (2015-2020)
Table 55. Europe Preventive Vaccines Sales Market Share by Type (2015-2020)
Table 56. China Preventive Vaccines Sales (K Doses) by Company (2015-2020)
Table 57. China Preventive Vaccines Sales Market Share by Company (2015-2020)
Table 58. China Preventive Vaccines Sales (K Doses) by Type (2015-2020)
Table 59. China Preventive Vaccines Sales Market Share by Type (2015-2020)
Table 60. China Preventive Vaccines Sales (K Doses) by Application (2015-2020)
Table 61. China Preventive Vaccines Sales Market Share by Application (2015-2020)
Table 62. Japan Preventive Vaccines Sales (K Doses) by Company (2015-2020)
Table 63. Japan Preventive Vaccines Sales Market Share by Company (2015-2020)
Table 64. Japan Preventive Vaccines Sales (K Doses) by Type (2015-2020)
Table 65. Japan Preventive Vaccines Sales Market Share by Type (2015-2020)
Table 66. Japan Preventive Vaccines Sales (K Doses) by Application (2015-2020)
Table 67. Japan Preventive Vaccines Sales Market Share by Application (2015-2020)
Table 68. Southeast Asia Preventive Vaccines Sales (K Doses) by Company (2015-2020)
Table 69. Southeast Asia Preventive Vaccines Sales Market Share by Company (2015-2020)
Table 70. Southeast Asia Preventive Vaccines Sales (K Doses) by Type (2015-2020)
Table 71. Southeast Asia Preventive Vaccines Sales Market Share by Type (2015-2020)
Table 72. Southeast Asia Preventive Vaccines Sales (K Doses) by Type (2015-2020)
Table 73. Southeast Asia Preventive Vaccines Sales Market Share by Application (2015-2020)
Table 74. India Preventive Vaccines Sales (K Doses) by Company (2015-2020)
Table 75. India Preventive Vaccines Sales Market Share by Company (2015-2020)
Table 76. India Preventive Vaccines Sales (K Doses) by Type (2015-2020)
Table 77. India Preventive Vaccines Sales Market Share by Type (2015-2020)
Table 78. India Preventive Vaccines Sales (K Doses) by Application (2015-2020)
Table 79. India Preventive Vaccines Sales Market Share by Application (2015-2020)
Table 80. Sanofi Corporation Information
Table 81. Sanofi Description and Business Overview
Table 82. Sanofi Preventive Vaccines Sales (K Doses), Revenue (Million USD), Price (USD/Doses) and Gross Margin (2015-2020)
Table 83. Sanofi Preventive Vaccines Product
Table 84. Sanofi Recent Development
Table 85. AstraZeneca Corporation Information
Table 86. AstraZeneca Description and Business Overview
Table 87. AstraZeneca Preventive Vaccines Sales (K Doses), Revenue (Million USD), Price (USD/Doses) and Gross Margin (2015-2020)
Table 88. AstraZeneca Preventive Vaccines Product
Table 89. AstraZeneca Recent Development
Table 90. CSL Ltd Corporation Information
Table 91. CSL Ltd Description and Business Overview
Table 92. CSL Ltd Preventive Vaccines Sales (K Doses), Revenue (Million USD), Price (USD/Doses) and Gross Margin (2015-2020)
Table 93. CSL Ltd Preventive Vaccines Product
Table 94. CSL Ltd Recent Development
Table 95. Abbott Corporation Information
Table 96. Abbott Description and Business Overview
Table 97. Abbott Preventive Vaccines Sales (K Doses), Revenue (Million USD), Price (USD/Doses) and Gross Margin (2015-2020)
Table 98. Abbott Preventive Vaccines Product
Table 99. Abbott Recent Development
Table 100. GlaxoSmithKline Corporation Information
Table 101. GlaxoSmithKline Description and Business Overview
Table 102. GlaxoSmithKline Preventive Vaccines Sales (K Doses), Revenue (Million USD), Price (USD/Doses) and Gross Margin (2015-2020)
Table 103. GlaxoSmithKline Preventive Vaccines Product
Table 104. GlaxoSmithKline Recent Development
Table . Serum Institute of India Corporation Information
Table . Serum Institute of India Description and Business Overview
Table . Serum Institute of India Preventive Vaccines Sales (K Doses), Revenue (Million USD), Price (USD/Doses) and Gross Margin (2015-2020)
Table . Serum Institute of India Preventive Vaccines Product
Table . Serum Institute of India Recent Development
Table 110. Production Base and Market Concentration Rate of Raw Material
Table 111. Key Suppliers of Raw Materials
Table 112. Preventive Vaccines Distributors List
Table 113. Preventive Vaccines Customers List
Table 114. Market Key Trends
Table 115. Key Opportunities and Drivers: Impact Analysis (2020-2026)
Table 116. Key Challenges
Table 117. Research Programs/Design for This Report
Table 118. Key Data Information from Secondary Sources
Table 119. Key Data Information from Primary Sources
List of Figures
Figure 1. Preventive Vaccines Product Picture
Figure 2. Global Preventive Vaccines Sales Market Share by Type in 2020 & 2026
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Preventive Vaccines Market Share by Application in 2020 & 2026
Figure 6. Hospital Examples
Figure 7. Clinic Examples
Figure 8. Other Examples
Figure 9. Global Preventive Vaccines Sales (K Doses) Growth Rate (2015-2026)
Figure 10. Global Preventive Vaccines Revenue (US$ Million) Growth Rate (2015-2026)
Figure 11. Global Preventive Vaccines Price Trends Growth Rate (2015-2026) (USD/Doses)
Figure 12. Global Preventive Vaccines Revenue Market Share by Region: 2015 VS 2020
Figure 13. Global Preventive Vaccines Revenue Market Share by Region: 2021 VS 2026
Figure 14. United States Preventive Vaccines Revenue (Million USD) Growth Rate (2015-2026)
Figure 15. United States Preventive Vaccines Sales (K Doses) Growth Rate (2015-2026)
Figure 16. Europe Preventive Vaccines Revenue (Million USD) Growth Rate (2015-2026)
Figure 17. Europe Preventive Vaccines Sales (Million USD) Growth Rate (2015-2026)
Figure 18. China Preventive Vaccines Revenue (Million USD) Growth Rate (2015-2026)
Figure 19. China Preventive Vaccines Sales (Million USD) and Growth Rate (2015-2026)
Figure 20. Japan Preventive Vaccines Revenue (Million USD) Growth Rate (2015-2026)
Figure 21. Japan Preventive Vaccines Sales (Million USD) Growth Rate (2015-2026)
Figure 22. Southeast Asia Preventive Vaccines Revenue (Million USD) Growth Rate (2015-2026)
Figure 23. Southeast Asia Preventive Vaccines Sales (Million USD) Growth Rate (2015-2026)
Figure 24. India Preventive Vaccines Revenue (Million USD) Growth Rate (2015-2026)
Figure 25. India Preventive Vaccines Sales (Million USD) Growth Rate (2015-2026)
Figure 26. Global 5 Largest Preventive Vaccines Players Market Share by Revenue in Preventive Vaccines 2015 & 2019
Figure 27. Preventive Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 28. Global Preventive Vaccines Revenue Share by Type (2015-2020)
Figure 29. Global Preventive Vaccines Revenue Growth Rate by Type in 2015 & 2019
Figure 30. Global Preventive Vaccines Revenue Share by Application (2015-2020)
Figure 31. Global Preventive Vaccines Revenue Growth Rate by Application in 2015 & 2019
Figure 32. United States Preventive Vaccines Sales Market Share by Type in 2019
Figure 33. United States Preventive Vaccines Sales Market Share by Type in 2019
Figure 34. Europe Preventive Vaccines Sales Market Share by Company in 2019
Figure 35. Europe Preventive Vaccines Sales Market Share by Type in 2019
Figure 36. Europe Preventive Vaccines Sales Market Share by Application in 2019
Figure 37. China Preventive Vaccines Sales Market Share by Company in 2019
Figure 38. China Preventive Vaccines Sales Market Share by Type in 2019
Figure 39. China Preventive Vaccines Sales Market Share by Application in 2019
Figure 40. Japan Preventive Vaccines Sales Market Share by Company in 2019
Figure 41. Japan Preventive Vaccines Sales Market Share by Type in 2019
Figure 42. Japan Preventive Vaccines Sales Market Share by Application in 2019
Figure 43. Southeast Asia Preventive Vaccines Sales Market Share by Company in 2019
Figure 44. Southeast Asia Preventive Vaccines Sales Market Share by Type in 2019
Figure 45. Southeast Asia Preventive Vaccines Sales Market Share by Application in 2019
Figure 46. India Preventive Vaccines Sales Market Share by Company in 2019
Figure 47. India Preventive Vaccines Sales Market Share by Type in 2019
Figure 48. India Preventive Vaccines Sales Market Share by Application in 2019
Figure 49. Sanofi Total Revenue (US$ Million): 2019 Compared with 2018
Figure 50. AstraZeneca Total Revenue (US$ Million): 2019 Compared with 2018
Figure 51. CSL Ltd Total Revenue (US$ Million): 2019 Compared with 2018
Figure 52. Abbott Total Revenue (US$ Million): 2019 Compared with 2018
Figure 53. GlaxoSmithKline Total Revenue (US$ Million): 2019 Compared with 2018
Figure 54. Serum Institute of India Total Revenue (US$ Million): 2019 Compared with 2018
Figure 55. Key Raw Materials Price Trend
Figure 56. Manufacturing Cost Structure of Preventive Vaccines
Figure 57. Manufacturing Process Analysis of Preventive Vaccines
Figure 58. Preventive Vaccines Industrial Chain Analysis
Figure 59. Channels of Distribution
Figure 60. Distributors Profiles
Figure 61. Porter's Five Forces Analysis
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
予防医学の世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The global Preventive Medicine market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Preventive Medicine marke…- 喘息予防の世界市場レポート2020 Asthma prophylaxis must be taken over a period of time to be effective. These drugs, however, are not suitable for the onset of the disease. Market Analysis and Insights: Global Asthma Preventive Market Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countrie…
- 喘息予防の世界市場レポート2020 A recently published report by QY Research titled Global Asthma Preventive Sales Market Report 2020 is designed in a way that helps the readers to acquire a complete knowledge about the overall market scenario and it’s most lucrative sectors. The research report also statistically provides accurate …
- 喘息予防の世界市場レポート2020 A recently published report by QY Research titled Global Asthma Preventive Sales Market Report 2020 is designed in a way that helps the readers to acquire a complete knowledge about the overall market scenario and it’s most lucrative sectors. The research report also statistically provides accurate …
- 喘息予防の世界市場レポート2020 Asthma prophylaxis must be taken over a period of time to be effective. These drugs, however, are not suitable for the onset of the disease. Market Analysis and Insights: Global Asthma Preventive Market Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countrie…